About this GHK-Cu digest

What GetGHKCu is

GetGHKCu is an independent editorial project that publishes summaries of the peer-reviewed research literature on GHK-Cu. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "get" in the domain name is editorial framing — a reader's-eye position toward the literature, an invitation to understand the compound. It is not a claim that this site supplies, dispenses, or sells GHK-Cu. Nothing here is for sale, and nothing here is a transaction.

How we handle the evidence

Every quantitative claim on this site — every dose, percentage, molecular weight, half-life and effect size — maps to a numbered citation on the references page, drawn from PubMed, PMC and peer-reviewed journals. We lead with what was measured and attribute it to its source.

We are deliberate about two things the GHK-Cu literature gets wrong often. First, the free peptide GHK and the copper chelate GHK-Cu are different molecules with different activity; we flag which form a study used. Second, the broad gene-modulation and systemic anti-aging claims rest largely on in-vitro data and one author group, while the strongest controlled human evidence is topical and dermatologic — we say so rather than blur the two ^[2][7].

What we do not do

We do not recommend doses for humans, describe how to use GHK-Cu, or frame any finding as guidance. We describe what was administered to a given model at a given concentration by a given route, and we stop there. The dosage page exists to report the concentrations studies used, not to tell anyone what to do with them.

We do not name commercial products, rank vendors, or link to sellers. We do not invent authors, credentials, or clinical staff. There is no "our team of doctors" here, because there is no team of doctors — there is an editor reading published papers and summarizing them with their citations attached.

This is a reading desk for a body of research — measured, cited, and final on the question of what the studies report, open on the question of what they mean for people. The regulatory status is plain: GHK-Cu has no approved therapeutic indication by any route; topical Copper Tripeptide-1 is a legal cosmetic ingredient, while injectable and systemic use is unapproved and research-only ^[7].